GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » Intermolecular Inc (NAS:IMI) » Definitions » Long-Term Capital Lease Obligation

Intermolecular (Intermolecular) Long-Term Capital Lease Obligation : $11.83 Mil (As of Jun. 2019)


View and export this data going back to 2011. Start your Free Trial

What is Intermolecular Long-Term Capital Lease Obligation?

Intermolecular's Long-Term Capital Lease Obligation for the quarter that ended in Jun. 2019 was $11.83 Mil.

Intermolecular's quarterly Long-Term Capital Lease Obligation increased from Dec. 2018 ($0.00 Mil) to Mar. 2019 ($12.31 Mil) but then declined from Mar. 2019 ($12.31 Mil) to Jun. 2019 ($11.83 Mil).


Intermolecular Long-Term Capital Lease Obligation Historical Data

The historical data trend for Intermolecular's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intermolecular Long-Term Capital Lease Obligation Chart

Intermolecular Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Intermolecular Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 12.31 11.83

Intermolecular  (NAS:IMI) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Intermolecular Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Intermolecular's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Intermolecular (Intermolecular) Business Description

Industry
Traded in Other Exchanges
N/A
Address
3011 North First Street, San Jose, CA, USA, 95134
Intermolecular Inc operates in the technology sector based in the United States. It manufactures and sells support materials for the semiconductor industry. Its HPC platform, which consists of the Tempus processing tools, automated characterization methods and Informatics analysis software, is purpose-built for research and development ("R&D") using combinatorial process systems in concert with established CVD, physical vapor deposition ("PVD") and atomic layer deposition ("ALD") deposition methods. It caters to semiconductor device, semiconductor materials and equipment and clean energy market companies primarily in the Asia-Pacific region.
Executives
Raging Capital Management, Llc 10 percent owner TEN PRINCETON AVENUE, PO BOX 228, ROCKY HILL NJ 08553-0228
Christian Kramer director, officer: President and CEO 6 DAVIS AVE APT B22, RYE NY 10580
Irwin Federman 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025
Kenneth H Traub director
William C Martin 10 percent owner C/O RAGING CAPITAL MANAGEMENT, LLC, TEN PRINCETON AVENUE, PO BOX 228, ROCKY HILL NJ 08553
Bill Roeschlein officer: Chief Financial Officer C/O SELECTICA, INC., 3 WEST PLUMERIA, SAN JOSE CA 95134
George Scalise director
Marvin D Burkett director C/O ENTEGRIS, INC., 129 CONCORD ROAD, BILLERICA MA 01821
Redpoint Ventures Ii, L.p. 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 290, MENLO PARK CA 94025
Redpoint Associates Ii, Llc 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 290, MENLO PARK CA 94025
Redpoint Ventures Ii, Llc 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 290, MENLO PARK CA 94025
Neil S Subin other: Former 10% Owner 2336 S.E. OCEAN BOULEVARD, #400, STUART FL 34996
Presidio Management Group Ix, L.l.c. 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025
Steven M Krausz 10 percent owner 2735 SAND HILL ROAD, MENLO PARK CA 94025
U S Venture Partners Ix L P 10 percent owner 2735 SAND HILL RD, MENLO PARK CA 94025

Intermolecular (Intermolecular) Headlines

From GuruFocus

WeissLaw LLP Investigates Intermolecular, Inc. Acquisition

By PRNewswire PRNewswire 05-16-2019